A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

Completed · Phase 3 · Has a placebo group

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

The purpose of this randomized, double-blind, crossover study is to compare two long-acting stimulant formulations-once-daily PRC-063 and once-daily lisdexamfetamine (LDX)-through a 15-hour period on driving performance, as measured with a driving simulator, in adult patients with ADHD.

Key facts

Study ID
NCT02555150
Run by
Rhodes Pharmaceuticals, L.P.
People needed
40
Starts
2015-09-01
Expected to finish
2017-01-01
Last updated by the study team
2017-01-19

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.